12 April 2020
This Guidance Note on making COVID-19 response Age & Disability-inclusive provides advice for organizations and sectors to ensure essential responses, communication about the outbreak and adapt to services and support are inclusive and accessible for older persons and persons with d...isabilities.
more
How to successfully apply for, administer, and manage the Zithromax® donation for trachoma elimination
In this COVID-19 pandemic, timely access to accurate information can be the difference between life and death. The stakes are high in developing countries like Ethiopia where millions of people have limited access to information because of low media access, insufficientin...ternet penetration, illiteracy, and language diversity.
more
Part of the CBM Prevention Toolkit on Cerebral Palsy
Diagnosis, Case Management Prevention and Control of Leptospirosis
Tuberculosis cases, TB deaths
International Journal of Infectious Diseases 32 (2015) 111–117
A toolkit for behavioural and social communication in outbreak response
The synthesis looked across the evaluations and reviews as mentioned above to draw lessons and conclusions across the different contexts. The synthesis aims to identify:
recurrent issues, patterns and trends, and promising initiatives and lessons learned from existing programming including main...streaming in how UNHCR prevents, mitigates and responds to the risks of SGBV;
institutional management and leadership for SGBV in UNHCR;
factors which are contributing to success, including sustainability of services, and those which are inhibiting it;
the extent to which questions on SGBV are part of UNHCR evaluations of emergency responses;
more
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid, ... diarrhoeagenic Escherichia coli and invasive non-‐typhi salmonella, penicillin-‐resistant Streptococcus pneu-‐moniae, vancomycin-‐resistant enterococci, methicillin-‐resistant Staphylococcus aureus and multidrug-‐re-‐sistant Mycobacterium tuberculosis. Resistance to medicines commonly used to treat malaria is of particu-‐lar concern, as is the emerging resistance to anti-‐HIV drugs. Often, more expensive medicines are required to treat these infections, and this becomes a major challenge in resource-‐poor settings.
more
Large size: Download directly from the website: https://www.washcluster.net/sites/gwc.com/files/2022-01/Unicef_Cholera%20Toolkit_2013.pdf
Reporting Period 2010-2011